DOJ Urges SCOTUS to Take Up Patent Eligibility

101 patent patent eligible subject matter

On May 24, 2022, the U.S. Solicitor General filed the government’s views on patent subject matter-eligibility as requested by the U.S. Supreme Court way back in May 2021.  The Solicitor General requested that the U.S. Supreme Court grant the petition for certiorari in American Axle & Manuf., Inc. v. Neapco Holdings LLC.[1]  The Solicitor General …

Continue Reading

Comment Period on Patent Eligibility Extended

101 IP Practicum patent patent eligible subject matter

On September 2, 2021, the U.S. Patent and Trademark Office extended the deadline for submission of comments regarding the state of patent eligibility and its effectiveness on U.S. investments and innovation.  The new date is October 15, 2021. The USPTO issued a notice on the Federal Register on July 9, 2021, requesting comments on patent …

Continue Reading

Method of Preparation Claims Patent-Eligible in Illumina Modified Opinion

101 fed circuit watch patent patent eligible subject matter

On August 3, 2020, the Court of Appeals for the Federal Circuit issued a modified opinion in Illumina, Inc. v. Ariosa Diagnostics, Inc.,[1] reiterating its earlier opinion[2] finding claims directed to method of preparing cell-free fetal DNA in maternal blood as patent-eligible subject matter under 35 U.S.C. §101.  This modified opinion reflected Ariosa’s recent petition …

Continue Reading

American Axle Denied en banc Review

101 fed circuit watch patent patent eligible subject matter

On July 31, 2020, the Court of Appeals for the Federal Circuit denied American Axle’s petition for en banc review, in American Axle & Manuf., Inc. v. Neapco Holdings LLC,[1] with those judges seeking review not able to muster a majority of the entire panel.  This is the second iteration[2] of appellate review for American …

Continue Reading

SCOTUS Watch: SCOTUS Decides Against Wading into 101 Quagmire

101 11th amendment patent patent eligible subject matter scotus watch sovereign immunity

On January 13, 2020, the U.S. Supreme Court denied petitions for writs of certiorari in four cases dealing with patent subject matter-eligibility: HP Inc. v. Berkheimer, Hikma Pharms., Inc. v. Vanda Pharms., Inc., Garmin USA, Inc. v. Cellspin Soft, Inc., and Athena Diagnostics, Inc. v. Mayo Collaborative Servs., which was discussed earlier on this blog.  …

Continue Reading

SCOTUS Watch: Patent Eligibility Showdown Looming Before Supreme Court

101 patent patent eligible subject matter scotus watch

On January 10, 2020, the U.S. Supreme Court will discuss at its first conference meeting whether or not to take up one to four cases dealing with patent eligibility under 35 U.S.C. §101.  Patent eligibility has been a contentious source of patent application rejections or invalidations during post-grant litigation.  Medical diagnostics and software have been …

Continue Reading

Garage Door Tech Not Patent-Eligible

101 103 fed circuit watch patent patent eligible subject matter wurc

On August 21, 2019, the Court of Appeals for the Federal Circuit held in The Chamberlain Group, Inc. v. Techtronic Inds. Co.,[1] that Chamberlain’s U.S. Patent No. 7,224,275 (‘275) directed to wireless communications technology for operating a movable barrier (i.e., garage door opener) was patent-ineligible subject matter under 35 U.S.C. §101. The ‘275 patent is …

Continue Reading

Fed Circuit Watch: Claim Construction Before Patent-Eligibility Analysis

101 fed circuit watch patent patent eligible subject matter

There have been several patent-eligibility rulings by the Court of Appeals for the Federal Circuit this year, but on August 16, 2019, the Fed Circuit held that claim construction in-dispute must be resolved before patent-eligibility under 35 U.S.C. §101 can be analyzed, in MyMail, Ltd. v. ooVoo, LLC.[1]  The somewhat circuitous procedural aspects of this …

Continue Reading

Fed Circuit Watch: Valuable Contribution Is Not Necessarily Patent-Eligible

101 fed circuit watch patent patent eligible subject matter

In a strange ruling by the Court of Appeals for the Federal Circuit, on July 29, 2019, although publicly released on August 9, 2019, in Genetic Veterinary Scis., Inc. v. Laboklin GmbH & Co KG,[1] the Fed Circuit found that in spite of the claimed invention’s “valuable contribution” to the veterinary sciences, it remained outside …

Continue Reading

Fed Circuit Watch: Issued Patents are Presumptively Valid and Patent-Eligible

101 fed circuit watch patent patent eligible subject matter

On June 25, 2019, the Court of Appeals for the Federal Circuit handed down CellSpin Soft, Inc. v. Fitbit, Inc.,[1] in what is an important case dealing with patent-eligibility under 35 U.S.C. §101, further hardening by the Fed Circuit that factual allegations in the pleadings can support patent-eligibility.  Further, Cellspin held that issued patents are …

Continue Reading